MARA Holdings
MARA
Coinbase
COIN
Apple
AAPL
Adobe
ADBE
Lennar Corp
LEN
US Stock MarketDetailed Quotes
CMMB Chemomab Therapeutics
- 1.660
- +0.030+1.84%
Trading Feb 27 11:40 ET
31.30MMarket Cap-1.77P/E (TTM)
1.672High1.620Low36.97KVolume1.620Open1.630Pre Close61.06KTurnover0.31%Turnover RatioLossP/E (Static)18.86MShares2.55052wk High1.92P/B19.62MFloat Cap0.57952wk Low--Dividend TTM11.82MShs Float184.000Historical High--Div YieldTTM3.18%Amplitude0.420Historical Low1.651Avg Price1Lot Size
Chemomab Therapeutics News
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adi Mor(4.8%),Kobi George(4.8%)
Chemomab Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Erik Otto(6.1%)
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%), etc.
Chemomab Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%), etc.
Chemomab Therapeutics | D: Filing D
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%), etc.
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%), etc.
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Darvish Nissim
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Quigley Jill M.
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Fatal Sigal
Chemomab Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Fatal Sigal
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Moses Alan Charles
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Neil Harris
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Darvish Nissim
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(19.7%),OrbiMed Israel GP Ltd.(19.7%)
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities
Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.